Filing Details

Accession Number:
0001209191-12-037463
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-05 21:17:14
Reporting Period:
2012-07-03
Filing Date:
2012-07-05
Accepted Time:
2012-07-05 20:17:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1491576 Tesaro Inc. TSRO Pharmaceutical Preparations (2834) 272249687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1276600 Khaled Nasr 2710 Sand Hill Road
Suite 200
Menlo Park CA 94025
No No Yes No
1460207 Interwest Management Partners X, Llc 2710 Sand Hill Road
Suite 200
Menlo Park CA 94025
No No Yes No
1553019 Keval Desai 2710 Sand Hill Road
Suite 200
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-03 2,627,257 $0.00 2,627,257 No 4 C Direct
Common Stock Acquisiton 2012-07-03 444,444 $13.50 3,071,701 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2012-07-03 9,195,402 $0.00 2,627,257 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. The Series B Preferred Stock converted into shares of TESARO, Inc. common stock on a 3.5 for 1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
  2. Reflects a 1-for-3.5 reverse stock split which beame effective on June 18, 2012
  3. The shares are owned by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10. Harvey B. Cash, Bruce A. Cleveland, Christopher B. Ehrlich, Philip T. Gianos, W. Stephen Holmes, Nina S. Kjellson, Gilbert H. Kliman, Arnold L. Oronsky, Douglas A. Pepper and Thomas L. Rosch are managing directors of IMP10. Keval Desai and Khaled A. Nasr are venture members of IMP10. Each managing director and venture member of IMP10 disclaims beneficial ownership of such shares, except to the extent of their pecuniary interest therein.